CoChat

Methamphetamine Use and Schizophrenia: A Population-Based Cohort Study in California

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Clinical investigators in Japan have long suggested that exposure to methamphetamine might cause a persistent schizophrenia-like psychosis. This possibility is discounted in the Western literature. To investigate the relationship between drug use and later schizophrenia, the authors conducted a large-scale cohort study of drug users initially free of persistent psychosis. METHOD: A population-based cohort study was conducted using data from California inpatient hospital discharge records from 1990 through 2000. Patients with methamphetamine-related conditions (N=42,412) and those with other drug use disorders (cannabis, cocaine, alcohol, and opioids) were propensity score-matched to individuals with primary appendicitis who served as a population proxy comparison group; the methamphetamine cohort was also matched to the other drug cohorts. Cox modeling was used to estimate differences between matched groups in the rates of subsequent admission with schizophrenia diagnoses. RESULTS: The methamphetamine cohort had a significantly higher risk of schizophrenia than the appendicitis group (hazard ratio=9.37) and the cocaine, opioid, and alcohol groups (hazard ratios ranging from 1.46 to 2.81), but not significantly different from that of the cannabis group. The risk of schizophrenia was higher in all drug cohorts than in the appendicitis group. CONCLUSIONS: Study limitations include difficulty in confirming schizophrenia diagnoses independent of drug intoxication and the possibility of undetected schizophrenia predating drug exposure. The study's findings suggest that individuals with methamphetamine-related disorders have a higher risk of schizophrenia than those with other drug use disorders, with the exception of cannabis use disorders. The elevated risk in methamphetamine users may be explained by shared etiological mechanisms involved in the development of schizophrenia.

Overview

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2011.10070937

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 5

  1. Angrist B, 1994, Amphetamine and Its Analogs: Pharmacology, Toxicology, and Abuse, 387
  2. Zach A, 1990, New Way to Edit: Discharge Data Review
  3. California Office of Statewide Health Planning and Development, 1995, Editing Criteria Handbook
  4. Sauerland S, 2004, Cochrane Database Syst Rev, 4, CD001546
  5. Konuma K, 1994, Amphetamine and Its Analogs: Pharmacology, Toxicology, and Abuse, 415

Cited by

See all 150

Metadata

Authors
Callaghan, R. C., Cunningham, J. K., Allebeck, P., Arenovich, T., Sajeev, G., Remington, G., Boileau, I., & Kish, S. J.
Affiliations
  • Centre for Addiction and Mental Health (CA)
  • From the Centre for Addiction and Mental Health, Toronto; the Dalla Lana School of Public Health, the Departments of Psychiatry and Pharmacology, Faculty of Medicine, and the Institute of Medical Science, University of Toronto, Toronto; the Department of Family and Community Medicine, University of Arizona, Tucson; and the Department of Public Health Sciences, Karolinska Institutet, Stockholm.
Venue
American Journal of Psychiatry
Published
2012-04
Volume
169
Issue
4
Pages
389-396
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2055556070
Cited by
150
References
30
Citations by year
2026: 3 · 2025: 4 · 2024: 9 · 2023: 9 · 2022: 6 · 2021: 10 · 2020: 6 · 2019: 8 · 2018: 10 · 2017: 9 · 2016: 13 · 2015: 35 · 2014: 9 · 2013: 13 · 2012: 6
FWCI
6.12
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Drug Abuse (R01DA025096, DA071301, DA025096)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords
methamphetamine use, schizophrenia, drug use disorders, cannabis use disorder, cocaine dependence, opioid use disorder, alcoholism, psychosis, hospital discharge data, propensity score matching, schizophrenia risk
MeSH terms
Adult, California, Female, Humans, Male, Methamphetamine, Middle Aged, Risk Factors, Schizophrenia, Schizophrenic Psychology, Cohort Studies, Diagnosis, Dual (Psychiatry), Amphetamine-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.